Table 2. Outcomes of HaH Program Participants vs Controls.
Outcome | Raw Valuesa | Modelsb | ||
---|---|---|---|---|
HaH | Controls | Unweighted Difference (SE), d | Weightedc Difference (SE), d | |
Acute length of stay, d | 3.2 (2.1) | 5.5 (3.4)d | −2.3 (0.11)d | −2.49 (0.14)d |
30-Day postacute period | OR (95% CI) | |||
All-cause hospital readmission | 25 (8.6) | 32 (15.6)e | 0.51 (0.40 to 0.65)d | 0.43 (0.36 to 0.52)d |
All-cause emergency department visit | 17 (5.8) | 24 (11.7)e | 0.47 (0.35 to 0.63)d | 0.39 (0.31 to 0.49)d |
Transfer to skilled nursing facility | 5 (1.7) | 22 (10.4)d | 0.15 (0.10 to 0.23)d | 0.09 (0.07 to 0.13)d |
Certified home health agency referral | 172 (58.3) | 104 (49.1)e | 1.45 (1.24 to 1.70)d | 1.09 (0.97 to 1.24) |
Abbreviations: HaH, hospital-at-home; OR, odds ratio; SE, standard error.
Unless otherwise indicated, all data are reported as number (percentage) of patients.
Multiply imputed models, vs control patients; models adjusted for age, sex, race and ethnicity, education, insurance type, impairments in activities of daily living, general health status, and admission diagnosis of congestive heart failure or urinary tract infection.
Inverse probability weighted.
P < .001.
P < .05.